Vacc-4x / Bionor 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Vacc-4x / Bionor
2015-003186-28: BIOSKILL: Studying Vacc-4x, an HIV therapeutic vaccine, an as-sessment of immune-mediated anti-viral effects, when administered with adjuvant GM-CSF prior to HIV latent reservoir activation by the HDAC inhibitor, romidepsin

Ongoing
2
192
Europe
Vacc-4x, Leukine, Istodax, Vacc-4x, -, Powder for solution for injection, Powder and solution for solution for injection, Leukine, Istodax
Bionor Pharma ASA, Bionor Pharma ASA
HIV infection, HIV infection, Diseases [C] - Virus Diseases [C02]
 
 

Download Options